Johnson & Johnson (JNJ) Meets EPS Estimate, Beats on Revenue; Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $268.73 --0%
Financial Fact:
Research and development expense: 2.18B
Today's EPS Names:
GBFH, JMKE, FDX, More
Financial Fact:
Research and development expense: 2.18B
Today's EPS Names:
GBFH, JMKE, FDX, More
Join SI Premium – FREE
(Updated - January 21, 2026 8:28 AM EST)
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.46, in line with the analyst estimate of $2.46. Revenue for the quarter came in at $24.6 billion versus the consensus estimate of $24.15 billion.
GUIDANCE:
Johnson & Johnson sees FY2026 EPS of $11.43-$11.63, versus the consensus of $11.49. Johnson & Johnson sees FY2026 revenue of $100-101 billion, versus the consensus of $98.9 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OppFi Inc. (OPFI) Tops Q3 EPS by 2c ; Offers Guidance
- Royal Caribbean Cruises (RCL) PT Raised to $360 at Susquehanna
- Orion Marine Group (ORN) Tops Q3 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
